Skip to main content
. 2018 Mar 19;9(36):24221–24236. doi: 10.18632/oncotarget.24823

Figure 5.

Figure 5

mRNA (A, C) and protein (B, D) expression of progesterone receptor (PR, A&B) and estrogen receptor-alpha (ER-α, C&D) as well as complement component 3 (C3) mRNA expression (E) in uterus of Sham mice and OVX mice treated with vehicle (OVX), genistein (G) or low (8PGL) or high (8PGH) dose of 8-prenylgenistein for 7 weeks. Values were expressed as means ± SEM, n = 10. #P < 0.05, ##P < 0.01, vs. Sham group; *P < 0.05, **P < 0.01, vs. OVX group.